Senhance 3-mm robot-assisted surgery: experience on first 14 patients in France

  • J. Montlouis-Calixte
  • B. Ripamonti
  • G. Barabino
  • T. Corsini
  • Céline ChauleurEmail author
Review Article


The objective of this article is to present our experience with the 3-mm instruments using the Senhance surgical robotic system in gynecological and abdominal surgery from July to December 2017 by a retrospective observational study. All patients who underwent a robot-assisted 3-mm laparoscopic procedure with the Senhance surgical robotic system were enrolled. Two separate populations were involved: nine female gynecological patients and five digestive surgery patients. Five cholecystectomies, three annexectomies, four ovarian cystectomies, one myomectomy and one endometriotic nodule resection were performed. For the gynecological cases, the median time spent at the console was 37 min (12–77), while the total duration of the intervention was 81.33 min. All the interventions were performed on an outpatient basis. There were no postoperative complications. The average visual analog scale for pain (VAS) was 2.11 (± 1.91) on D0. For the abdominal surgery cases, the median time was 39 min (21–64). The average total duration of the intervention was 87.4 min (± 36.82). One of the five interventions was performed on an outpatient basis. There was one laparoscopy conversion. No postoperative complications in the 2 weeks following the operation. There are few 3-mm instruments available with the Senhance surgical robotic system, which limits the number of interventions. However, it is possible to perform gynecological interventions with 3-mm instruments on an outpatient basis in complete safety. It is possible to perform cholecystectomies by pairing the use of 3-mm and 5-mm instruments. The recent arrival of new 3-mm instruments will enable a wider range of surgical indications.


Senhance surgical robotic system 3 mm Robot-assisted laparoscopy Gynecology Cholecystectomy 



We are grateful to Paula Harry for English revision and editorial assistance.

Compliance with ethical standards

Conflict of interest

J. Montlouis Calixte, B. Ripamonti, G. Barabino, T. Corsini, C. Chauleur declare that they have no conflict of interest and nothing to disclose.

Ethical approval

All procedures followed were in accordance with the 1964 Helsinki Declaration and approved by the ethical committee institutional. Informed consent was obtained from all patients included in the study.


  1. 1.
    Rossitto C, Gueli Alletti S, Fanfani F, Fagotti A, Costantini B, Gallotta V et al (2016) Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery. Int J Med Robot 12:490–495CrossRefGoogle Scholar
  2. 2.
    Leal Ghezzi T, Campos Corleta O (2016) 30 years of robotic surgery. World J Surg 40:2550–2557CrossRefGoogle Scholar
  3. 3.
    Rao PP (2018) Robotic surgery: new robots and finally some real competition! World J Urol 36:537–541CrossRefGoogle Scholar
  4. 4.
    Gaia G, Holloway RW, Santoro L, Ahmad S, Di Silverio E, Spinillo A (2010) Robotic-assisted hysterectomy for endometrial cancer compared with traditional laparoscopic and laparotomy approaches: a systematic review. Obstet Gynecol 116:1422–1431CrossRefGoogle Scholar
  5. 5.
    Fanfani F, Restaino S, Gueli Alletti S, Fagotti A, Monterossi G, Rossitto C et al (2015) TELELAP ALF-X robotic-assisted laparoscopic hysterectomy: feasibility and perioperative outcomes. J Minim Invasive Gynecol 22:1011–1017CrossRefGoogle Scholar
  6. 6.
    Gueli Alletti S, Rossitto C, Cianci S, Scambia G (2016) Telelap ALF-X total hysterectomy for early stage endometrial cancer: new frontier of robotic gynecological surgery. Gynecol Oncol 140:575–576CrossRefGoogle Scholar
  7. 7.
    Fanfani F, Monterossi G, Fagotti A, Rossitto C, Gueli Alletti S, Costantini B et al (2016) The new robotic TELELAP ALF-X in gynecological surgery: single-center experience. Surg Endosc 30:215–221CrossRefGoogle Scholar
  8. 8.
    Gueli Alletti S, Rossitto C, Cianci S, Perrone E, Pizzacalla S, Monterossi G et al (2018) The SenhanceTM surgical robotic system (« Senhance ») for total hysterectomy in obese patients: a pilot study. J Robot Surg 12:229–234CrossRefGoogle Scholar
  9. 9.
    Rossitto C, Gueli Alletti S, Perrone E, Monterossi G, Scambia G (2017) Treatment of gynecological disease in obese patient: which role for telelap ALF-X platform? J Robot Surg 11:95–96CrossRefGoogle Scholar
  10. 10.
    Rossitto C, Gueli Alletti S, Romano F, Fiore A, Coretti S, Oradei M et al (2016) Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy. Int J Med Robot 12:613–619CrossRefGoogle Scholar
  11. 11.
    Spinelli A, David G, Gidaro S, Carvello M, Sacchi M, Montorsi M et al (2017) First experience in colorectal surgery with a new robotic platform with haptic feedback. Colorectal Dis 20:228–235CrossRefGoogle Scholar
  12. 12.
    Gueli Alletti S, Perrone E, Cianci S, Rossitto C, Monterossi G, Bernardini F et al (2018) 3 mm Senhance robotic hysterectomy: a step towards future perspectives. J Robot Surg 12:575–577CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Gynecology and ObstetricsUniversity HospitalSaint-ÉtienneFrance
  2. 2.Department of General SurgeryUniversity HospitalSaint-ÉtienneFrance
  3. 3.INSERM U1059Saint-ÉtienneFrance
  4. 4.University of LyonSaint-ÉtienneFrance
  5. 5.Department of Gynecology and ObstetricsSaint-Etienne University Hospital Centre, North HospitalSaint Priest en JarezFrance

Personalised recommendations